Naples, Italy

Laura Cerchia


 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 78(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Laura Cerchia: Innovator in RNA Aptamer Technology

Introduction

Laura Cerchia is a prominent inventor based in Naples, Italy. She has made significant contributions to the field of RNA aptamer technology, holding a total of 4 patents. Her work focuses on developing innovative solutions for diagnosing and treating diseases associated with specific growth factor receptors.

Latest Patents

One of her latest patents involves the creation of nuclease-resistant RNA aptamers that can neutralize PDGFRβ. These aptamers are particularly useful in the diagnosis and therapy of PDGFRβ-associated diseases, including cancer and primary tumor metastasis. The invention includes a modified synthetic RNA sequence where at least one pyrimidine residue is altered to 2'-fluoropyrimidine. Additionally, she has developed an EGFR aptamer inhibitor designed for therapeutic and diagnostic purposes. This nucleotide aptamer has a specific sequence that can be utilized in the treatment, prevention, and diagnosis of disorders induced by EGFR.

Career Highlights

Laura Cerchia has worked with esteemed organizations such as the National Research Council of Italy (Consiglio Nazionale Delle Ricerche). Her research has significantly advanced the understanding and application of RNA aptamers in medical science.

Collaborations

Throughout her career, Laura has collaborated with notable colleagues, including Vittorio De Franciscis and Gerolama Condorelli. These partnerships have further enriched her research and innovation in the field.

Conclusion

Laura Cerchia's contributions to RNA aptamer technology exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a leading inventor in this critical area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…